Risk analysis of cardiovascular toxicity in patients with lymphoma treated with CD19 CAR T cells

MLA

Yang Liu, et al. “Risk Analysis of Cardiovascular Toxicity in Patients with Lymphoma Treated with CD19 CAR T Cells.” Journal of Translational Medicine, vol. 23, no. 1, Jan. 2025, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s12967-024-06035-4.

APA

Yang Liu, Xiaoshuang Yuan, Xu Yang, Bo Yang, Guangyang Liu, Xiao Xu, Sanbin Wang, Zhixu He, Feiqing Wang, & Yanju Li. (2025). Risk analysis of cardiovascular toxicity in patients with lymphoma treated with CD19 CAR T cells. Journal of Translational Medicine, 23(1), 1–15. https://doi.org/10.1186/s12967-024-06035-4

Chicago

Yang Liu, Xiaoshuang Yuan, Xu Yang, Bo Yang, Guangyang Liu, Xiao Xu, Sanbin Wang, Zhixu He, Feiqing Wang, and Yanju Li. 2025. “Risk Analysis of Cardiovascular Toxicity in Patients with Lymphoma Treated with CD19 CAR T Cells.” Journal of Translational Medicine 23 (1): 1–15. doi:10.1186/s12967-024-06035-4.